These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10127940)

  • 1. T2 news worsens with poor earnings.
    Burns J
    Mod Healthc; 1993 Aug; 23(35):35. PubMed ID: 10127940
    [No Abstract]   [Full Text] [Related]  

  • 2. Reserve fund drives Coram loss.
    Burns J
    Mod Healthc; 1994 Aug; 24(34):20-1. PubMed ID: 10135687
    [No Abstract]   [Full Text] [Related]  

  • 3. Home infusion depresses Medical Care revenues.
    Lutz S
    Mod Healthc; 1993 Jan; 23(3):12. PubMed ID: 10123645
    [No Abstract]   [Full Text] [Related]  

  • 4. Home i.v. therapy companies target insurers, HMOs for future growth.
    Lutz S
    Mod Healthc; 1987 Mar; 17(6):96, 99. PubMed ID: 10281052
    [No Abstract]   [Full Text] [Related]  

  • 5. Former chief halts attempt to acquire T2.
    Burns J
    Mod Healthc; 1993 Sep; 23(37):17. PubMed ID: 10128182
    [No Abstract]   [Full Text] [Related]  

  • 6. Home care forum: cost viewpoints.
    Weinstein SM
    NITA; 1987; 10(6):401-9. PubMed ID: 3320816
    [No Abstract]   [Full Text] [Related]  

  • 7. Hospitals poised to offer in-home i.v. therapy.
    Robinson ML
    Hospitals; 1989 Jul; 63(14):16, 20. PubMed ID: 2666297
    [No Abstract]   [Full Text] [Related]  

  • 8. Home infusion therapy: comparison of costs for intravenous immunoglobulin.
    Bielory L; Long GC
    N J Med; 1993 Jul; 90(7):512-5. PubMed ID: 8355890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How self-referrals can go sour. The travails of T2 and its doctor investors.
    Sternberg S
    Med Econ; 1994 Jun; 71(11):116-27. PubMed ID: 10134208
    [No Abstract]   [Full Text] [Related]  

  • 10. Unissued rules worry home care providers.
    Lutz S
    Mod Healthc; 1989 Sep; 19(35):34, 36. PubMed ID: 10303811
    [No Abstract]   [Full Text] [Related]  

  • 11. Home iv therapy benefit of the Catastrophic Coverage Act: it's impact on home care providers.
    Marren J; Rodgers B; Dishon M
    Pride Inst J Long Term Home Health Care; 1989; 8(3):15-8. PubMed ID: 10303818
    [No Abstract]   [Full Text] [Related]  

  • 12. Home intravenous drug therapy under Medicare.
    Leader S
    Pride Inst J Long Term Home Health Care; 1989; 8(3):8-14. PubMed ID: 10303820
    [No Abstract]   [Full Text] [Related]  

  • 13. Homedco and Abbey among companies that have viewed T2's books.
    Burns J
    Mod Healthc; 1994 Jan; 24(5):10. PubMed ID: 10131365
    [No Abstract]   [Full Text] [Related]  

  • 14. Home infusion therapy meets managed care: confrontation or cooperation.
    Winters RW
    Med Interface; 1994 Jul; 7(7):72-4, 85. PubMed ID: 10135994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A high-priced hookup.
    Lord M
    US News World Rep; 1994 May; 116(18):63-4, 67-9. PubMed ID: 10133811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medicare program; payment for home intravenous drug therapy services--HCFA. Proposed rule.
    Fed Regist; 1989 Nov; 54(215):46938-53. PubMed ID: 10303985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The home infusion industry: patients' angel or their ruthless plunderer?
    Margolis RE
    Healthspan; 1993 Jun; 10(6):18-20. PubMed ID: 10127303
    [No Abstract]   [Full Text] [Related]  

  • 18. T2 agrees to 4-way merger that will create 2nd-largest home infusion company.
    Burns J
    Mod Healthc; 1994 Feb; 24(7):32. PubMed ID: 10131772
    [No Abstract]   [Full Text] [Related]  

  • 19. Homedco's earnings up 19% in 2nd quarter.
    Burns J
    Mod Healthc; 1994 Jun; 24(26):74. PubMed ID: 10134995
    [No Abstract]   [Full Text] [Related]  

  • 20. Shares of T2 Medical rise on buyout talk.
    Lutz S
    Mod Healthc; 1993 May; 23(22):10. PubMed ID: 10126259
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.